Embecta EMBC
NASDAQ EMBC
$6.71 -0.15 (-2.19%)
At close: Oct 23, 2026 · 4:00 PM EDT

Embecta (EMBC) Gains from Sales and Divestitures (2025)

Updated

Embecta (EMBC) posted Gains from Sales and Divestitures of $10.1 million for fiscal Q1 2026 (quarter ended Dec 31, 2025).

Analysis

Embecta (EMBC) Gains from Sales and Divestitures (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Embecta 392.10 Mn -434.30 Mn 153.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.10 Mn
API Access

Embecta Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=EMBC&period=max&api_key=YOUR_API_KEY